Associate Professor of Medicine Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts
Caron A. Jacobson, MD, MMSc, is an oncolgist who specializes in lymphoma at the Dana-Farber Cancer Institute. She does clinical and translational research in lymphoma and in CAR T-cell therapy and is the medical director of the Immune Effector Cell Therapy Program at DFCI, which oversees both the commercial CAR T-cell programs in lymphoma and leukemia, as well as the research programs in all engineered cell therapies, which span multiple different disease centers.